Related references
Note: Only part of the references are listed.Incretin hormones: Their role in health and disease
Michael A. Nauck et al.
DIABETES OBESITY & METABOLISM (2018)
Cardiovascular outcomes with glucagon-like peptide-1 receptor agonists in patients with type 2 diabetes: a meta-analysis
M. Angelyn Bethel et al.
LANCET DIABETES & ENDOCRINOLOGY (2018)
Efficacy and Safety of ITCA 650, a Novel Drug-Device GLP-1 Receptor Agonist, in Type 2 Diabetes Uncontrolled With Oral Antidiabetes Drugs: The FREEDOM-1 Trial
Julio Rosenstock et al.
DIABETES CARE (2018)
Efficacy and safety of liraglutide versus sitagliptin both in combination with metformin in patients with type 2 diabetes A systematic review and meta-analysis
Mingxing Li et al.
MEDICINE (2017)
Effects of liraglutide on weight, satiation, and gastric functions in obesity: a randomised, placebo-controlled pilot trial
Houssam Halawi et al.
LANCET GASTROENTEROLOGY & HEPATOLOGY (2017)
The Sustained Effects of a Dual GIP/GLP-1 Receptor Agonist, NNC0090-2746, in Patients with Type 2 Diabetes
Juan Pablo Frias et al.
CELL METABOLISM (2017)
The effects of GLP-1 based therapies on postprandial haemodynamics: Two randomised, placebo-controlled trials in overweight type 2 diabetes patients
Mark M. Smits et al.
DIABETES RESEARCH AND CLINICAL PRACTICE (2017)
Biological Activity and Antidiabetic Potential of C-Terminal Octapeptide Fragments of the Gut-Derived Hormone Xenin
Christine M. Martin et al.
PLOS ONE (2016)
Why cholecystokinin and gastrin are also incretins
Jens F. Rehfeld
CARDIOVASCULAR ENDOCRINOLOGY (2016)
Synergistic metabolic benefits of an exenatide analogue and cholecystokinin in diet-induced obese and leptin-deficient rodents
J. L. Trevaskis et al.
DIABETES OBESITY & METABOLISM (2015)
A rationally designed monomeric peptide triagonist corrects obesity and diabetes in rodents
Brian Finan et al.
NATURE MEDICINE (2015)
GLP-1/Glucagon Coagonism Restores Leptin Responsiveness in Obese Mice Chronically Maintained on an Obesogenic Diet
Christoffer Clemmensen et al.
DIABETES (2014)
Characterisation of the biological activity of xenin-25 degradation fragment peptides
Christine M. A. Martin et al.
JOURNAL OF ENDOCRINOLOGY (2014)
The novel GLP-1-gastrin dual agonist, ZP3022, increases ß-cell mass and prevents diabetes in db/db mice
K. Fosgerau et al.
DIABETES OBESITY & METABOLISM (2013)
Unimolecular Dual Incretins Maximize Metabolic Benefits in Rodents, Monkeys, and Humans
Brian Finan et al.
SCIENCE TRANSLATIONAL MEDICINE (2013)
Beginnings: A reflection on the history of gastrointestinal endocrinology
Jens F. Rehfeld
REGULATORY PEPTIDES (2012)
Incretin physiology beyond glucagon-like peptide 1 and glucose-dependent insulinotropic polypeptide: cholecystokinin and gastrin peptides
J. F. Rehfeld
ACTA PHYSIOLOGICA (2011)
Combination Therapy With a Dipeptidyl Peptidase-4 Inhibitor and a Proton Pump Inhibitor Induces beta-Cell Neogenesis From Adult Human Pancreatic Duct Cells Implanted in Immunodeficient Mice
Wilma L. Suarez-Pinzon et al.
CELL TRANSPLANTATION (2011)
Gastrin Treatment Stimulates β-Cell Regeneration and Improves Glucose Tolerance in 95% Pancreatectomized Rats
Noelia Tellez et al.
ENDOCRINOLOGY (2011)
Evaluation of the degradation and metabolic effects of the gut peptide xenin on insulin secretion, glycaemic control and satiety
Ashley I. Taylor et al.
JOURNAL OF ENDOCRINOLOGY (2010)
Changes in Gastrointestinal Hormones and Leptin after Roux-en-Y Gastric Bypass Procedure: A Review
Lauren M. Beckman et al.
JOURNAL OF THE AMERICAN DIETETIC ASSOCIATION (2010)
Combination Therapy With Glucagon-Like Peptide-1 and Gastrin Restores Normoglycemia in Diabetic NOD Mice
Wilma L. Suarez-Pinzon et al.
DIABETES (2008)
Progressive rise in gut hormone levels after Roux-en-Y gastric bypass suggests gut adaptation and explains altered satiety
CM Borg et al.
BRITISH JOURNAL OF SURGERY (2006)
Combination therapy with epidermal growth factor and gastrin increases β-cell mass and reverses hyperglycemia in diabetic NOD mice
WL Suarez-Pinzon et al.
DIABETES (2005)
The [pre-] history of the incretin concept
W Creutzfeldt
REGULATORY PEPTIDES (2005)
Distribution of CCK1 and CCK2 receptors in normal and diseased human pancreatic tissue
JC Reubi et al.
GASTROENTEROLOGY (2003)
The rise of gastrointestinal endocrinology since 1970 and Jens F. Rehfeld and his group right in the middle of it
W Creutzfeldt
SCANDINAVIAN JOURNAL OF CLINICAL & LABORATORY INVESTIGATION (2001)
Share Paper
